Nuvectra Submits Chemical Composition and Biocompatibility Data to FDA for Virtis™
October 18, 2019 08:00 ET
|
Nuvectra Corporation
PLANO, Texas, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced it has submitted supplementary chemical composition...
Nuvectra® Appoints Jennifer Kosharek as Chief Financial Officer
September 20, 2019 08:30 ET
|
Nuvectra Corporation
PLANO, Texas, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Jennifer Kosharek as Chief...
Nuvectra® Exploring Strategic Options to Enhance Shareholder Value
August 26, 2019 16:05 ET
|
Nuvectra Corporation
PLANO, Texas, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that its Board of Directors has decided to explore...
Nuvectra® Reports Second Quarter 2019 Financial Results
July 31, 2019 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, July 31, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended June...
Nuvectra to Report Second Quarter 2019 Financial Results on July 31, 2019
July 17, 2019 08:30 ET
|
Nuvectra Corporation
PLANO, Texas, July 17, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the...
Nuvectra® to Participate in Two Upcoming Investor Conferences
June 12, 2019 16:05 ET
|
Nuvectra Corporation
PLANO, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that members of management are scheduled to...
Nuvectra Files Regulatory Submission with FDA for Algovita® Full-Body MR-Conditional Approval
June 11, 2019 16:05 ET
|
Nuvectra Corporation
PLANO, Texas, June 11, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has filed its regulatory submission with the...
Nuvectra Highlights Positive Preliminary Algovita® Clinical Data at the INS 14th Annual World Congress
May 30, 2019 08:30 ET
|
Nuvectra Corporation
PLANO, Texas,, May 30, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today preliminary Algovita® clinical data from its U.S. and...
Nuvectra® Announces Departure of COO & CFO Walter Z. Berger
May 16, 2019 09:00 ET
|
Nuvectra Corporation
PLANO, Texas, May 16, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that Walter Z. Berger has resigned as Nuvectra’s Chief...
Nuvectra® Reports First Quarter 2019 Financial Results
May 01, 2019 16:01 ET
|
Nuvectra Corporation
PLANO, Texas, May 01, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31,...